Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery
Cell Reports Methods · 2023
DOI: 10.1016/j.crmeth.2023.100511 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Reports Methods, 2023. Verfasst von Charlotte Stutzmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHU Sainte Justine Research Center, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Microfluidics, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, FRQS.
Abstract (Originalsprache)
The identification of tumor-specific antigens (TSAs) is critical for developing effective cancer immunotherapies. Mass spectrometry (MS)-based immunopeptidomics has emerged as a powerful tool for identifying TSAs as physical molecules. However, current immunopeptidomics platforms face challenges in measuring low-abundance TSAs in a precise, sensitive, and reproducible manner from small needle-tissue biopsies (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU Sainte Justine Research Center, Montreal, QC, Canada.
- Department of Chemistry, University of Toronto, Toronto, ON, Canada.
- Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada.
- Department of Chemistry, University of Montreal, Montreal, QC, Canada.
- Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada.
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
Förderung
- CIHR
- Canadian Institutes of Health Research
- FRQS
- Chung Hua University
- Cole Foundation
- Natural Sciences and Engineering Research Council of Canada
- Fondation Charles-Bruneau
- CQDM
Zitieren
APA
Stutzmann, C., Peng, J., Wu, Z., Savoie, C., Sirois, I., Thibault, P., Wheeler, A. R., & Caron, E. (2023). Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery. Cell Reports Methods. https://doi.org/10.1016/j.crmeth.2023.100511
Vancouver
Stutzmann C, Peng J, Wu Z, Savoie C, Sirois I, Thibault P, et al. Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery. Cell Reports Methods. 2023. doi:10.1016/j.crmeth.2023.100511
BibTeX
@article{Stutzmann2023,
author = {Stutzmann, Charlotte and Peng, Jiaxi and Wu, Zhaoguan and Savoie, Christopher and Sirois, Isabelle and Thibault, Pierre and Wheeler, Aaron R and Caron, Etienne},
title = {Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery},
journal = {Cell Reports Methods},
year = {2023},
doi = {10.1016/j.crmeth.2023.100511}
}
EUVIMED